• Users Online: 533
  • Print this page
  • Email this page


 
 
Table of Contents
ORIGINAL ARTICLE
Year : 2017  |  Volume : 8  |  Issue : 2  |  Page : 94-98

Prevalence of squamous intraepithelial lesion among women in Kaduna State, Nigeria


1 Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Kaduna State, Nigeria
2 Department of Obstetrics and Gynaecology, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria
3 Department of Histopathology, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria

Date of Web Publication21-Feb-2018

Correspondence Address:
Miss. Sheba J Magaji
C/o. Prof. Maryam Aminu, Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, P.M.B. 1008, Zaria, Kaduna State
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/atp.atp_5_17

Get Permissions

  Abstract 

Background: Cervical cancer is one of the most common cancers in women. Human papillomavirus (HPV) infection is the primary cause of virtually all cervical cancers. Cervical cancer typically develops from precancerous changes, squamous intraepithelial lesion (SIL) over a period of 10–20 years, in about 5%–10% HPV-infected individuals. This study was carried out to determine the prevalence and risk factors of SIL among women in Kaduna State, Nigeria. Materials and Methods: This study was a hospital-based and cross-sectional study that combined the use of a structured questionnaire and analysis of cervical scrapings samples obtained from 276 consenting women in Kaduna State, Nigeria. The samples were analyzed for SIL using conventional Papanicolaou smear. Results: The prevalence rate of 6.2% for SIL was obtained with low-grade SIL being the most common type of cervical abnormality. Sociodemographic factors associated with the development of SIL in the study were marriage type, level of education, and occupation (P ≤ 0.05). The risk factors that were associated to the development of SIL in the study were multiple sexual partners and high parity (P ≤ 0.05). The symptoms associated with SIL were intermenstrual bleeding, dyspareunia, and postcoital bleeding. Conclusion: The prevalence of SIL obtained from this study is appreciable, and this calls for the institution of awareness programs for HPV-associated cervical cancer and the implementation of a routine cervical cancer screening program in Kaduna State, Nigeria.

Keywords: Cervical cancer, human papillomavirus, Nigeria, Pap smear, uterine cervix, women


How to cite this article:
Magaji SJ, Aminu M, Inabo HI, Oguntayo AO, Ahmed SA, Yaro JD, Suleiman DE, Lawal M. Prevalence of squamous intraepithelial lesion among women in Kaduna State, Nigeria. Ann Trop Pathol 2017;8:94-8

How to cite this URL:
Magaji SJ, Aminu M, Inabo HI, Oguntayo AO, Ahmed SA, Yaro JD, Suleiman DE, Lawal M. Prevalence of squamous intraepithelial lesion among women in Kaduna State, Nigeria. Ann Trop Pathol [serial online] 2017 [cited 2019 Jun 20];8:94-8. Available from: http://www.atpjournal.org/text.asp?2017/8/2/94/225918


  Introduction Top


Cervical cancer is one of the most common cancers among women, particularly in developing countries.[1] Human papillomavirus (HPV) infection has been implicated in the development of more than 90% of cases as it causes cervical dysplasia, which if untreated, can develop into cancer.[2] Cervical cancer typically develops from precancerous changes over 10–20 years period.[1]

The evidence for the development of human cancer by HPV has been determined through the HPV-E6 gene product which in turn binds to the human p53 tumor suppressor protein as the initiating event.[3] Cervical cancer is completely preventable if precancerous cell changes are detected and treated early before cervical cancer develops.[4]

Other risk factors to cervical carcinogenesis include; low immune status, poor nutrition, tobacco smoking, high parity, prolonged use of oral contraceptives, genetic disorders, early sexual debut, uncircumcision of the male partner, and coinfection with other sexually-transmitted agents such as HIV, herpes simplex virus type 2, and Chlamydia trachomatis.[5]

Worldwide, about 751 women die from cervical cancer every day and more than 80% of these deaths come from Sub-Saharan Africa. In Nigeria, 14,000–20,000 new cases are diagnosed every year, while 9659 deaths occur every year translating to the loss of 26 women every day.[6]

The increase in cases of mortality due to HPV-associated cervical cancer necessitates the establishment and/or reinforcement of a routine National Cervical Cancer Screening Program in Nigeria. In most states in Nigeria, Kaduna inclusive, there is still very poor awareness of the high prevalence of HPV-associated cervical cancer as well as cervical cancer screening services.[7] Consequently, this study seeks to provide information on the prevalence of squamous intraepithelial lesion (SIL) in Kaduna State, and the outcome of this research will, therefore, improve the prospects on the implementation of the said cervical cancer screening program at both the state and national level.


  Materials and Methods Top


Study area and ethical considerations

This study was a hospital-based and cross-sectional study, and it was conducted in 3 different hospitals from the 3 senatorial zones of Kaduna State, Nigeria. Ethical Approval was obtained from the Health Research Ethics Committee of Ahmadu Bello University Teaching Hospital, Zaria, as well as from the Kaduna State Ministry of Health before the study commenced and informed consent was sorted from the respondents before sample and data collection. Structured questionnaire was used to collect sociodemographic and clinical information from consenting women.

Sample size

The prevalence rate of 18.6% from a previous study in southern Nigeria [8] was used to determine the sample size, using the equation derived by Sarmukaddam and Garad [9] at 95% confidence interval. Cervical scrapings samples were collected from 276 women, aged 15 years and above that were sexually active. The study population included pregnant women, nonpregnant women, and women under treatment with antiretroviral drugs all of which consented. The study excluded women who had recently (<3 years ago) screened for  Pap smear More Details who know their result whether they were under treatment or not, women diagnosed with cervical cancer or with symptoms of cervical cancer, and women who were not sexually active as well as women who did not give consent.

Sample collection and analysis

A sterile cytobrush was used to collect the excoriated cells from the squamocolumnar junction of the ecto and endocervix by a gynecologist. The cells were then smeared on a clean glass slide, fixed immediately in 95% alcohol, stained with Papanicolaou technique as described by the University of Nottingham Medical School [10] and reported using the Bethesda Classification 2001[11] by pathologists at the Ahmadu Bello University Teaching Hospital, Shika, Kaduna State. The samples were collected over 6 months.

Data analysis

Data were analyzed statistically using the frequency procedure of Statistical Analysis System (SAS) version 9.2 (SAS Institute Inc., North Carolina State University, USA), at 0.05 level of significance and 95% confidence interval. The relationships between variables were determined using Fisher's exact test, and the degree of association between SIL and risk factors was quantified using odds ratio (OR).


  Results Top


Analysis of the study population by sociodemographic features revealed that most (52.9%: 146/276) of the respondents were between ages 37 and 56 years (standard deviation [SD] = ±2.082). A good number (217) of the respondents were married civil servants (142) that had attended the tertiary level of education (123), mostly from other tribes (233) aside from the three major tribes in Nigeria. Concerning their sexual and reproductive characteristics, most (47.5%: 131/276) of the respondents were multiparous women who practice monogamy (228) and had their first sexual contact at or after age 20 (189).

The result of the Pap smear [Table 1] revealed that of the 276 respondents, 17 (6.2%) had SIL. Of the 17 respondents that had abnormal Pap smear, 11.8% (2/17) had atypical squamous cells of undetermined significance (ASC-US), 76.5% had low-grade SIL (LGSIL) and 11.8% (2/17) had high-grade SIL (HGSIL). The proportion of these abnormalities is summarized in [Figure 1].
Table 1: Prevalence of squamous intraepithelial lesion among women in Kaduna State, Nigeria

Click here to view
Figure 1: Distribution of squamous intraepithelial lesion among Women in Kaduna State, Nigeria (n = 17). ASC-US: Atypical squamous cell of undetermined significance, LGSIL: Low-grade squamous intraepithelial lesion, HGSIL: High-grade squamous intraepithelial lesion

Click here to view


Analysis of the cytology result by age [Table 2] showed that women in age group 67–76 years (SD = ±3.245) had the highest rate of occurrence of SIL (22.2%: 2/9), while the least prevalence (4.9%: 4/81) was seen in respondents within age group 37–46 years (SD = ±2.900) (χ2 = 29.096, df = 5, P = 0.3107).
Table 2: Prevalence of squamous intraepithelial lesion based on some sociodemographic features among women attending some hospitals in Kaduna State, Nigeria

Click here to view


SIL was not seen in the single women (ladies that had never married) that were sexually exposed, and women who were in a polygamous marriage had the highest rate of occurrence of SIL (8.3%:3/36). There was a strong statistical association between the occurrence of SIL and marriage type (χ2 = 20.027, df = 1, P = 0.0027).

Women who had their first sexual contact between age 13 and 16 years (SD = ±2.434) had the highest SIL prevalence (13.6%: 3/22) [Table 3]. SIL was, however, not statistically associated with age at first sexual contact (χ2 = 19.772, df = 2, P = 0.0424). It was observed that women who had multiple sexual partners had a higher prevalence of SIL (9.3%: 7/75) (χ2 = 19.691, df = 1, P = 0.0381, OR = 0.491).
Table 3: Distribution of squamous intraepithelial lesion based on some sexual features and risk factors among women in Kaduna State, Nigeria

Click here to view


Further analysis of the results revealed that women who had given birth five times or more (grand multiparous) had the highest prevalence of SIL (8.8%: 8/91) (χ2 = 19.615, df = 3, P = 0.0514).

In this study, 16 women were found to be infected with HIV, out of which 1 had SIL, and there was no significant association between infection with HIV and HPV (χ2 = 10.001, df = 1, P = 0.4642, OR =0.004). Similarly, the use of sexual enhancers was not associated with SIL (χ2 = 11.331, df = 1, P = 0.4336, OR = 0.000).

The prevalence of SIL based on some clinical features presented by the respondents indicated that SIL was highly associated with intermenstrual bleeding (χ2 = 23.052, df = 1, P = 0.0031, OR = 0.100), occurring in 11.8% (4/34) of them [Figure 2]. Furthermore, there was a higher prevalence of SIL (33.3%: 2/6) in women who had postcoital bleeding compared to those that did not (5.6%: 15/270). There was a statistically significant association between postcoital bleeding and SIL occurrence (χ2 = 25.601, df = 1, P = 0.0046, OR = 0.020). One of the fifteen respondents that complained of dyspareunia had SIL (χ2 = 27.635, df = 1, P = 0.0545, OR = 0.004).
Figure 2: Distribution of squamous intraepithelial lesion based on some clinical features suggestive of cervical cancer among Women in Kaduna State, Nigeria. Key: IMB: Intermenstrual bleeding, PCB: Postcoital bleeding, DPN: Dyspareunia. Yes: Presence of any of the defined clinical features, No: Absence of any of the defined clinical features

Click here to view



  Discussion Top


The prevalence of abnormal smear in the study area was found to be 6.2%, which is similar to the 6.0% reported in Kano State by Auwal et al.[12] and 5.7% reported in Spain.[13] This prevalence is, however, higher than the 3.1% reported in South Italy,[14] and much lower than 54.5% reported among women in Maiduguri.[15] These observed differences in the prevalence could be due to the different sociocultural practices such as marriage practices, religious policies, diet, medical treatment options, and interpersonal relationships at the different regions as well as differences in the population studied. The 6.2% prevalence rate obtained from this implies that SIL is not uncommon in the study area and if these lesions are not treated, there is a measurable probability that they will result to cancer of the cervix in the near future. This finding necessitates the reinforcement of the Cervical Cancer Screening Program in the state and the need for women to go for this screening as frequent as required.

It was observed that LGSIL was the most common cervical lesion found in Pap smear results. This contrasts with the report of Ammatuna et al.[14] It also does not agree with existing reports that say ASC-US is the most common form of cervical abnormality as reported by cytology laboratories.[16] The higher number of women with LGSIL as compared to ASCUS could be because most of the women in this study had never done Pap smear before; therefore, the lack of discovery and treatment of the mildest cervical dysplasia (ASCUS) would have resulted to progression to LGSIL. The management of women with LGSIL largely depends on their HPV status. There is the need for immediate colposcopy and treatment in HPV-positive women who have LGSIL, as there is a 19% chance of developing HGSIL and cancer.[17] However, HPV-negative women who have LSIL only need to do a repeat of the Pap smear 6–12 months before further actions are taken.[17]

Older women within the age group of 67–76 years had the highest rate of occurrence of SIL. This finding is consistent with that of Fadahunsi et al.[8] and Tao et al.[18] but contrasted that of Rama et al.[19] The high occurrence of SIL in older women could be explained by the fact that it takes a very long period (15–20 years) before infection with high-risk-HPV transforms to precancerous and later cancerous lesion.[20] It is a pointer to the high possibility of these set of women not going or Pap smear screening, consequently, it emphasizes the need for women, especially younger women to get involved in an active cervical cancer screening on a routine basis, this will reduce the chances of developing such lesions.

Sexual debut at a younger age and multiple sexual partners increases chances of having cervical cancer.[21] This statement is consistent with the findings of this study, where women who had sex before the age of 16 had the highest rate of SIL. It was speculated that the increased risk of HPV is because of a biological predisposition of the immature cervix during adolescence that may be more susceptible to persistent HPV infections and therefore have a greater risk of developing SIL.[22]

Furthermore, there was a statistically significant association between number of sexual partners and the development of SIL which implies that the more number of sexual partners one have, the higher chances are that they develop SIL in the future.[18] It was observed in this study that women who had multiple sexual partners were 0.5 times more at risk of developing SIL than women with single sexual partner. This is in line with the report of Centre for Disease Control and Prevention.[22]

Women who were grand multiparous had the highest prevalence of SIL compared to the nulliparous women. This finding agrees with the reports of Muñoz et al.[23] and National Cancer Institute [1] reported that women who have had multiple deliveries were at a higher risk of developing SIL. The serum concentrations of estrogen and progesterone increase as pregnancy progresses and peaks during the third trimester, and these increase may be associated with the development of an atypical transformation zone and squamous metaplasia at the endo/ectocervical junction.[24] Having many pregnancies is, therefore, associated with an increased risk of cervical cancer.

There are certain clinical manifestations that could be indices of cervical dysplasia or possibly cervical cancer. Analysis of SIL based on these clinical features indicated that SIL was highly statistically associated with intermenstrual bleeding, postcoital bleeding, and pain during coitus, and this agrees with the with the findings of Tao et al.[18] These symptoms have been reported as some of the clinical manifestations of cervical cancer, which supports the association that was found between the features and SIL in this study.[1],[25]


  Conclusion Top


The SIL is not uncommon in the study area, thus necessitating the establishment of a routine cervical cancer screening program in Kaduna State and the need for policy formulation on cervical cancer screening. There is a need to create awareness on the risk factors for cervical cancer in Kaduna State, Nigeria.

Acknowledgments

We thank the staff of the Obstetrics and Gynaecology Departments of General Hospital, Kafanchan, Barau Dikko Teaching Hospital, Kaduna and Ahmadu Bello University Teaching Hospital, Zaria, for their assistance in the collection of samples. We also appreciate the Head of the Laboratory Department of General Hospital, Kafanchan, and Barau Dikko Teaching Hospital, Kaduna, for providing the storage facility for the samples collected. We owe a big gratitude to the Laboratory personnel of the Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, for assisting in staining the slides and the pathologists in the same Department for reporting the slides.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
National Cancer Institute. Cervical Cancer Treatment; 2015. Available from: http://www.cancer.gov/types/cervical/patient/cervical-treatment-pdq. [Last retrieved on 2016 Feb 09].  Back to cited text no. 1
    
2.
World Health Organization. Fact Sheet No. 297: Cancer; 2015. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/. [Last retrieved on 2016 Apr 30].  Back to cited text no. 2
    
3.
Chaturvedi A, Maura LG. Human papillomavirus and head and neck cancer. In: Olshan AF, editor. Epidemiology, Pathogenesis, and Prevention of Head and Neck Cancer. 1st ed. New York: Springer; 2010. p. 87-116.  Back to cited text no. 3
    
4.
American Sexual Health Association. National HPV and Cervical Cancer Prevention Resource Center; 2015. Available from: http://www.ashasexualhealth.org/stdsstis/hpv. [Last accessed on 2015 Oct 13].  Back to cited text no. 4
    
5.
American Cancer Society. What Are the Risk Factors for Cervical Cancer? 2015. Available from: http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-risk-factors?. [Last accessed on 2015 Oct 13].  Back to cited text no. 5
    
6.
Onwudiwe E, Motunrayo J. Sexually Active Women Prone to Cervical Cancer 2014. With in Punch News Paper; 22nd June, 2014. Available from: http://www.punchng.com/health/sexually-active-women-prone-cervical-cancer--expert/. [Last accessed on 2014 Sep 17].  Back to cited text no. 6
    
7.
Mfuh AY, Lukong CS. Women's views on knowledge and barriers to cervical cancer screening among women in Kaduna State, Nigeria. Greener J Epidemiol Public Health 2016;4:44-55. Available from: http://www.gjournals.org/GJEPH/Publication/2016/October/HTML/082116131%20Mfuh%20and%20Lukong.htm. [Last accessed on 2017 Dec 07].  Back to cited text no. 7
    
8.
Fadahunsi OO, Omoniyi-Esan GO, Banjo AA, Esimai OA, Osiagwu D. Prevalence of high risk oncogenic human papillomavirus types in cervical smears of women attending well woman clinic in Ile Ife, Nigeria. Obstet Gynecol2013;3:185.  Back to cited text no. 8
    
9.
Sar Mukaddam SB, Garad SG. Validity of assumption while determining sample size. Indian J Community Med 2006;29:2004-6.  Back to cited text no. 9
    
10.
University of Nottingham Medical School: Division of Histopathology. Papanicolaou Method; 1997. Available from: http://www.nottingham.ac.uk/pathology/protocols/papacytol.html. [Last accessed on 2016 Mar 08].  Back to cited text no. 10
    
11.
Apgar BS, Zoschnick L, Wright TC Jr. The 2001 Bethesda system terminology. Am Fam Physician 2003;68:1992-8.  Back to cited text no. 11
[PUBMED]    
12.
Auwal IK, Aminu M, Atanda AT, Tukur J, Sarkinfada F. Prevalence and risk factors of high risk Human papillomavirus infections among women attending gynaecology clinics in Kano, Northern Nigeria. Bayero J Pure Appl Sci 2013;6:67-71.  Back to cited text no. 12
    
13.
de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N, et al. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003;30:788-93.  Back to cited text no. 13
    
14.
Ammatuna P, Giovannelli L, Matranga D, Ciriminna S, Perino A. Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev 2008;17:2002-6.  Back to cited text no. 14
    
15.
Ojiyi EC, Okeudo C, Dike E, Anolue F, Onyeka U, Audu B, et al. The prevalence and predictors of Human papilloma virus infection of the cervix at a university teaching hospital in Northern Nigeria. Internet J Gynecol Obstet 2012;16:2.  Back to cited text no. 15
    
16.
American Congress of Obstetricians and Gynecologist. Abnormal Cervical Cancer Test Results; 2016. Available from: http://www.m.acog.org/Patients/FAQs/Abnormal-Cervical-Cancer-Screening-Test-Results?IsMobileSet=true. [Last accessed on 2016 Jul 25].  Back to cited text no. 16
    
17.
Schiffman M, Solomon D. Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting. N Engl J Med 2013;369:2324-31.  Back to cited text no. 17
    
18.
Tao L, Han L, Li X, Gao Q, Pan L, Wu L, et al. Prevalence and risk factors for cervical neoplasia: A cervical cancer screening program in Beijing. BMC Public Health 2014;14:1185.  Back to cited text no. 18
    
19.
Rama CH, Roteli-Martins CM, Derchain SF, Longatto-Filho A, Gontijo RC, Sarian LO, et al. Prevalence of genital HPV infection among women screened for cervical cancer. Rev Saude Publica 2008;42:123-30.  Back to cited text no. 19
    
20.
Kahn JA. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med 2009;361:271-8.  Back to cited text no. 20
    
21.
Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, et al. Sexual behaviour in context: A global perspective. Lancet 2006;368:1706-28.  Back to cited text no. 21
    
22.
Centre for Disease Control and Prevention. What are the Risk Factors for Cervical Cancer?; 2014. Available from: http://www.cdc.gov/cancer/cervical/basic_info/risk_factors.htm. [Last accessed on 2016 Apr 16].  Back to cited text no. 22
    
23.
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.  Back to cited text no. 23
    
24.
Malik AI. The role of human papilloma virus (HPV) in the aetiology of cervical cancer. J Pak Med Assoc 2005;55:553-8.  Back to cited text no. 24
    
25.
Centre for Disease Control and Prevention. Human Papilloma Virus Signs and Symptoms 2015. Available from: http://www.cdc.gov/hpv/parents/signs-symptoms.html. [Last retrieved on 2016 Apr 30].  Back to cited text no. 25
    


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1], [Table 2], [Table 3]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
Introduction
Materials and Me...
Results
Discussion
Conclusion
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed834    
    Printed47    
    Emailed0    
    PDF Downloaded66    
    Comments [Add]    

Recommend this journal